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Complete re-sequencing of a 2Mb
topological domain encompassing the
FTO/IRXB genes identifies a novel obesity-
associated region upstream of IRX5
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Abstract
Background: Association studies have identified a number of loci that contribute to an increased body mass
index (BMI), the strongest of which is in the first intron of the FTO gene on human chromosome 16q12.2.
However, this region is both non-coding and under strong linkage disequilibrium, making it recalcitrant to
functional interpretation. Furthermore, the FTO gene is located within a complex cis-regulatory landscape
defined by a topologically associated domain that includes the IRXB gene cluster, a trio of developmental
regulators. Consequently, at least three genes in this interval have been implicated in the aetiology of obesity.
Methods: Here, we sequence a 2 Mb region encompassing the FTO, RPGRIP1L and IRXB cluster genes in 284
individuals from a well-characterised study group of Danish men containing extremely overweight young
adults and controls. We further replicate our findings both in an expanded male cohort and an independent
female study group. Finally, we compare our variant data with a previous study describing IRX3 and FTO
interactions in this region.
Results: We obtain deep coverage across the entire region, allowing accurate and unequivocal determination
of almost every single nucleotide polymorphism and short insertion/deletion. As well as confirming previous
findings across the interval, we identify a further novel age-dependent association upstream of IRX5 that
imposes a similar burden on BMI to the FTO locus.
Conclusions: Our findings are consistent with the hypothesis that chromatin architectures play a role in regulating
gene expression levels across topological domains while our targeted sequence approach represents a widely applicable
methodology for high-resolution analysis of regional variation across candidate genomic loci.
Background
Previous genome-wide association studies (GWAS)
have consistently identified single nucleotide polymor-
phisms (SNPs) associated with obesity located within
the first intron of the FTO gene on human chromo-
some 16q12.2 [1–3]. Findings from these studies have
been confirmed in meta-analyses wherein the associ-
ated SNPs are in strong linkage disequilibrium (LD)
with one another. The strongest association is found
for SNP rs1121980:C > T with an odds ratio of 1.66
among 929 Caucasians [2]. This variant is in LD with
a number of other SNPs (r2 ≥ 0.88 for all), including
rs9939609:T > A, which has been the most extensively
genotyped. The rs9939609 risk allele (A) has an odds
ratio itself of 1.34 for heterozygotes and 1.55 for
homozygotes [4]. This association has also been iden-
tified for type 2 diabetes (T2D); however when adjust-
ing for body mass index (BMI), the T2D association
is lost suggesting that this association is a secondary
effect of BMI [1].
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The association of obesity with rs9939609:T > A has
been replicated in many independent study groups
across a range of different ethnicities [5–10]. However,
the degree of linkage disequilibrium across the entire
intron 1 of FTO has prevented a single potentially func-
tional SNP from being identified, although trans-ethnic
comparison has permitted a degree of fine mapping of
the region [11]. The LD region identified in the HapMap
Phase II data spans about 50 kb, covering part of the
first intron of FTO, the second exon and a small portion
of the second intron [12]. Despite this, coding SNPs in
the second exon of FTO have not been found to follow
the same association patterns.
As a result of the persistent association with obesity in
this region, the function of the nearest gene, FTO, has
been under close scrutiny. FTO is a ubiquitously
expressed N6-methyladenosine demethylase [13], yet
there are conflicting data and models of how changes in
FTO expression might affect function and phenotype.
Mouse models have been informative; knockdown of
FTO in mice results in reduced fat mass, suggesting that
the susceptibility to obesity could be through over-
expression of FTO [14]. A further mouse FTO knockout
has been described generated through replacement of
exons 2 and 3 with a neomycin STOP cassette [15]. This
mouse exhibits growth retardation from postnatal day 2
onwards although it also shows a broader range of phe-
notypes including higher postnatal death. It supports the
hypothesis that FTO is involved in energy metabolism
and body weight regulation as the knockout mice show
a reduction in adipose tissue and increased energy ex-
penditure. However, eQTL analyses examining the links
between the associated SNPs and the expression levels
of FTO have not to date identified a clear and direct
correlation [16–18].
A few hundred bases upstream of FTO, and tran-
scribed in the opposite direction, is the RPGRIP1L gene.
As a result of its proximity to the LD region, the func-
tion of this gene has also been closely examined on the
premise that non-coding SNPs might affect the regula-
tory landscape acting in cis on this nearby gene. Some
evidence to this effect has been reported [19] and
Rpgrip1l+/− mouse models gain weight more rapidly than
their wild-type litter mates, as well as exhibiting in-
creased energy intake and increased adiposity [20].
More recently, chromosome conformation capture
(3C) approaches have demonstrated that longer-range
interactions occur across this region acting at both the
FTO and IRX3 gene promoters [21] although the con-
cept of long-range regulation in this region has been
speculated upon previously [22]. These studies point to
IRX3 as a further potential candidate gene that might
interact with the associated SNPs in the first intron of
FTO. In the paralogous IRXA cluster (encompassing
IRX1, IRX2 and IRX4 at a separate genomic location on
chromosome 5), there has already been some enhancer
analysis that suggests co-regulation of all three genes
[23]. Therefore it might be that a similar pattern of distal
cis-regulation operates at this obesity-associated locus.
Further evidence to support this comes from the ana-
lysis of topologically associated domain (TAD) structure
in mammalian genomes. Data from embryonic stem cells
identify a TAD of approximately 2 Mb that neatly en-
compasses the IRXB cluster, FTO and RPGRIP1L genes
(chr16:53,562,500-55,442,500) [24]. Hence perturbation
of the transcriptional architecture within this region dur-
ing development could potentially impact upon any or
all of these genes, and lead to an altered BMI phenotype.
Finally, it is of note that this region contains hundreds
of deeply conserved non-coding elements (CNEs), se-
quences implicated in the long-range cis-regulation of
genes during development, including the IRX genes.
Variants in such sequences might result in altered gene
expression profiles across the region. Interestingly, the
locations of CNEs at the IRXB cluster span from 53.56
to 55.48 Mb, in remarkably close agreement to the
boundaries of the TAD [24, 25].
Here, using custom enrichment, we generate and ana-
lyse the complete sequence of 284 Danish males homo-
zygous at rs9939609 across the 2 Mb TAD region. The
resulting deep and comprehensive coverage allows us to
identify over 14,000 SNPs and short indels permitting
the precise and complete construction of haplotypes
without the need for imputation. The use of homozy-
gotes for the FTO LD region facilitates the downstream
analysis of haplotypes. We identify a novel association
that implicates the IRX5 gene region in obesity and com-
pare our results with previously derived interaction data
for the region. We then replicate our findings in an ex-
panded male cohort and in a separate female study
group using accurate imputation calls, and identify an
age dependent association, consistent with previous
studies [26, 27]. Finally, our study provides a high qual-
ity, single base resolution resource for further study into
the complex genetics of obesity across human chromo-
some 16q12.2, and a general methodology for targeted
sequencing and analysis of variation across large gen-
omic regions in general.
Results
Strategy and study group
We employed a custom in-solution hybridisation ap-
proach to capture and completely sequence a 2 Mb region
of chromosome 16 encompassing the RPGRIP1L, FTO
and IRX3, 5 and 6 genes from 288 Danish men, previously
genotyped as homozygous at rs9939609 (A/A or T/T)
[28]. The region (53.5 to 55.5 Mb) was specifically selected
to encompass a TAD defined in embryonic stem cells
Hunt et al. Genome Medicine  (2015) 7:126 Page 2 of 14
(53.56–55.44 Mb) (24). Our study group comprises 126
cases with a BMI of ≥31.0 kg/m2 and 162 control samples
(Additional file 1: Table S1). They originate from two
larger series of men selected from the study popula-
tion of Danish men (n = 362,200) examined at
mandatory draft board assessment during the years
1943 through 1977 [28]. The case set represents all
men with a BMI ≥31.0 kg/m2 at initial assessment,
corresponding to those above the approximately 99.5
percentile, whereas the control group consists of a
randomly selected 1 % of all men in the original
study population and is thus representative of the
underlying population’s distribution of BMI values.
The case group and half of the control group have
been used in several follow-up studies including one in
1998–2000 where additional blood sampling allowed
extraction of high quality DNA [28–33]. As a result
of this sampling design, our study group has a bi-
modal distribution of BMI values and enrichment for
homozygosity across the LD region encompassing the
obesity-associating SNPs. The average BMI for the
controls is 21.5 compared to 33.2 for the cases
(Table 1). BMI values are calculated from the original
draft board assessment. The rs9939609:T > A (risk) al-
lele was present in our study group at 41.9 %. In
1000 Genomes Project (1KG) data, both the Finnish
(FIN) and British (GBR) allele frequency (AF) of the
minor allele is 39.3 % [34]. Therefore, despite our enrich-
ment for homozygosity, we have a similar representation
of the risk allele compared to the general population. The
study group also maintains the relative proportions of T/T
to A/A individuals (1.9:1 in controls and 0.9:1 in cases)
found in the larger case and control group from which
our individuals are derived [28].
Sequencing and variant calling
We used 96-plex indexing to construct custom libraries
for 288 samples. We generated 1.66 billion paired end
reads from these libraries for a total of 166 Gb of
sequence. Approximately 75 % of reads map back
uniquely to the 2 Mb region of interest (chr16:53,500,000-
55,500,000) giving an average of 4 million reads per
sample (200-fold coverage). Our sequencing identified
one genotyping error (a genotyped A/A individual
that was actually A/T), one sample failed to run, and
two samples (1 case T/T, 1 control T/T) were of low
coverage and had missing genotypes for more than 50 %
of variants. These were removed from subsequent ana-
lyses resulting in a final set of 284 samples (161 controls
and 123 cases). As expected, coverage varied extensively
both between samples and across the region. Nevertheless,
277 samples have greater than 10-fold coverage across at
least 90 % of the region (Additional file 2: Figure S1)
allowing comprehensive, single base resolution analysis
and unequivocal variant calling.
We developed an in-house variant calling algorithm
‘TidyVar’ (methods – B. Noyvert and G. Elgar, manuscript
in preparation). The algorithm is fundamentally different
from that of commonly used variant calling software
GATK [35]. TidyVar can be accurately deployed across any
region of DNA of any size and from any species. Across
the two-megabase interval, 14,101 variants passed quality
control, of which 13,373 are simple (bi-allelic) and 728 are
‘complex’, in that they have more than one non-reference
allele. Of the 13,373 simple variants, 12,392 are SNPs and
981 are indels. Fifty-nine percent of these variants are iden-
tically catalogued in the phase 1 release of 1KG project
data [34] and 74 % are identically catalogued in dbSNP
build 142 [36]. On average, each individual has 2,869 vari-
ants across the region (ranging from 2,178 to 3,377).
We compared minor allele frequency (MAF) for those
bi-allelic SNPs present in both our whole study group
and the 1KG project (Fig. 1). Reassuringly, the two data-
sets correlate very closely, demonstrating that despite
selecting only homozygotes, the fact that we frequency
matched rs9939609:T > A with the general European
population results in a broadly representative set of vari-
ant frequencies.
We looked for copy-number variations (CNV) and
found that four individuals, all of whom are obese,
have an 11.6 Kb deletion (esv2659911) on one allele
at chr16:54,408,013-54,419,653. The probability that
four randomly picked samples are cases is significant
at the 5 % level (P value = 0.034). However, based on
this small study alone, we are not able to firmly es-
tablish if this deletion is associated with obesity in
the general population.
Distribution of variants across constrained sequences
Within the 2 Mb interval sequenced in this study, 225
conserved CNEs are highly conserved between mammals
and fish (CONDOR [25]) covering a total of more than
Table 1 Study group details
rs9939609
T/T (%) A/A (%) Total (%) Average BMI Variance (95 % CI) Standard error from mean
Controls. BMI <31 kg/m2 106 (37.3) 55 (19.4) 161 (56.7) 21.5 ±0.4 4.3
Cases. BMI ≥31 kg/m2 59 (20.8) 64 (22.5) 123 (43.3) 33.2 ±0.5 5.6
Total 165 (58.1) 119 (41.9) 284 (100) 26.5 ±0.7 7.1
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25 kb. In addition, there is 17.2 kb of coding sequence
across the region. We examined the number and distri-
bution of SNPs in these different classes of constrained
DNA (Table 2, Additional file 3: Figure S2, Additional
file 4: Figure S3). As expected, there is a lower density of
SNPs in coding sequences and to a lesser extent in
CNEs, than in the remainder of the non-coding DNA
across the region. SNPs in coding sequences and CNEs
also have lower mean MAFs than general non-coding
DNA, reflecting an excess of rare variants (Additional
file 5: Figure S4). These data reflect differing levels of
functional constraint at these sites. However, the number
of variants per individual does not differ significantly
between cases and controls in any class of sequence.
Haplotype analysis
Haplotype analysis of the entire region (using pairwise
comparison of SNPs up to 500 kb apart) permits the
identification of blocks with high LD (Additional file 6:
Figure S5), the most notable of which is the previously
Fig. 1 Variant frequencies across the 2 Mb interval. The allele frequency of each variant in our study group is plotted against its frequency in European
populations from the 1,000 Genomes Project. Only variants identified in both sets of data in the same format are directly compared (n = 8338). Two
SNPs give very high values in our study group but low values in the Europeans population; these are artefacts caused by simple sequence repeats
Table 2 Variant summary data for chr16q12.2 classified by functional region and BMI status
Region Size of region (kb) Number of variant locations Variant locations
per Kb
Mean MAF Average number variants
per individual
Average number non-ref
alleles per individual
CNEs 25.1 Cases 117 4.66 0.118 20.03 27.52
Controls 109 4.34 0.127 19.94 27.60
Total 141 5.61 0.098 19.98 27.57
Coding 17.2 Cases 38 2.21 0.075 4.61 5.37
Controls 56 3.26 0.051 4.75 5.40
Total 70 4.07 0.041 4.69 5.39
Non-coding 1,957.7 Cases 11014 5.51 0.181 2853 3916
Controls 11826 5.91 0.167 2836 3892
Total 13980 6.94 0.142 2843 3902
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identified 44 kb region (chr16:53,799,296-53,843,533) in
the first intron of the FTO gene containing rs9939609.
Three distinct haplotypes persist across this interval and
comprise 63.5 % of all haplotypes across the region. The
first two (29.3 % and 12.5 %) differ by just one SNP
(rs113191842:A > G) and account for all the rs9939609
A/A individuals (known henceforth as haplotype AH44).
While the more common of these two haplotypes
strongly associates with the obesity case group (Fig. 2) as
expected (P = 1 × 10-4), the second does not (P = 0.383)
although this might simply reflect a lack of statistical
power due to its low frequency in the study group over-
all. The third common haplotype (21.7 %) is found only
in T/T individuals, but does not show a significant asso-
ciation with either case or control (P = 0.086) group.
Additional file 7: Table S2 describes all the other haplo-
type blocks with associations to the case or control
group with a frequency of >0.05. Due to the number of
individuals sequenced in this study, we have focused on
the two regions showing the clearest and most strongly
associating variants. There are several other LD blocks
containing haplotypes that also associate with either case
or control outside of these regions, however further se-
quencing would be needed to establish any association
of these blocks in the general population.
The AH44 haplotype
The obesity-associated haplotype, along with its al-
most identical sub-haplotype (referred to collectively
henceforth as AH44) has a clear and distinct pattern
of variation across its length when compared to other
haplotypes for the same region. This haplotype en-
compasses many of the obesity-associated SNPs that
have been identified by various GWAS studies [37].
From our in depth analysis, 114/122 highly poly-
morphic SNPs (MAF >0.35) spanning 53,798,523 to
53,848,561 (50.038 kb) are in complete LD with
rs9939609 in all A/A individuals in our study group.
Of the remaining 8/122 SNPs, seven are uniquely het-
erozygous in the same individual and the final SNP
also occurs just once. While these common SNPs are
essentially in complete LD across the 44 kb AH44
haplotype, there are a number of rarer variants across
the region that are not in LD, indicating that while
the common variants are retained, there are in fact
numerous sub-haplotypes that contribute to AH44.
The most frequent of these rarer alleles that separates the
two AH44 haplotypes (see above), rs113191842:A >G at
53,817,318 (just over 3 kb from rs9939609:T > A), is only
present in AH44 but occurs at a frequency of 0.28 within
this population. A further 26 non-unique and 21 unique
Fig. 2 Allele frequencies for each variant across the 2 Mb interval compared between controls and cases. Variants within the AH44 LD block are
in red and variants in the second association region upstream of IRX5 are in green
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variants are present within the AH44 haplotype individ-
uals, while just one of these (rs16952522:C > G) is shared
with the non-AH44 haplotype in T/T individuals.
Identification of a novel region associated with BMI in our
study group
We used Haploview [38] to compare the frequency of
every SNP across the 2 Mb interval between cases and
controls and to calculate the case-control allelic associ-
ation P values (Fig. 3 and methods). The known LD
region in the first intron of FTO (chr16:53,797,908-
53,846,168) is clearly defined (Fig. 4a). In addition, we
also observe a second peak of association approximately
1 Mb away that consists of a cluster of SNPs upstream
of the IRX5 gene (16:54,820,000-54,860,000). Critically,
this case specific association is independent of risk allele
rs9939609 (Additional file 6: Figure S5 and Additional
file 8: Figure S6). Furthermore, random shuffling of the
cases and controls results in loss of any comparable
signal across the region (Additional file 9: Figure S7).
The non-coding region encompasses four linkage
disequilibrium blocks, the largest of which is 38 kb in
size (Fig. 4b). Within this LD block, there are several
haplotypes identified by Haploview.
The strongest obesity associating haplotype (P value =
0.002) occurs at a frequency of 0.49 in the case group
and 0.36 in controls. No other haplotype in this LD block
has a total frequency above 0.13 suggesting that the associ-
ating haplotype is more robust in its entirety than the mul-
tiple non-associating haplotypes. The 38 kb associating
region encompasses 213 SNPs that we have identified in
our sequencing, 78 of which are tagged by Haploview for
use in haplotyping. Thirty-five SNPs within this LD block
have an association P value <0.05. The lowest 10 % of P
values for SNPs in this region (n = 21) range from 0.0002
to 0.0073. The three highest associating SNPs in this
second peak (P = 0.0002) are in complete LD within 7 kb
of each other in all but two individuals. These SNPs
(rs7186407:A > T, rs12598453:C >G and rs12596270:A >
G, hg19 coordinates chr16: 54837068, 54843731,
54843981, respectively) are present at a frequency of 0.491
in controls and 0.646 in cases (0.56 in whole study group),
Fig. 3 Association of SNPs in cases vs. controls. Minus log10(P value) of Case/Control association for each SNP across the 2 Mb interval generated from
Haploview [38] and represented by vertical blue lines. The first peak (at 53.82 Mb) in the intron of FTO shows the known association at rs9939609:T > A
and reflects the strong linkage disequilibrium across that region. The second peak (54.84 Mb) indicates a novel associated region upstream of IRX5
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whereas they have a wide range of derived allele frequen-
cies in different populations in the 1KG Project, with
values as low as 0.0225 to 0.036 in Japanese and Chinese
populations, to greater than 0.5 in all European popula-
tions. Individuals in the study group who have neither risk
region allele rs9939609:T > A (from known region)
nor rs12598453:C > G from our novel region have a
mean BMI of 23.86, whereas individuals homozygous
for either risk region have significantly higher mean
BMIs of 27.96 (Mann-Whitney P value = 0.0062) and
27.60 (P value = 0.0088), respectively (28.90 if homo-
zygous for both (P value = 0.00067)). Thus, both
regions have a similar association with BMI.
Multiple testing correction
The P values presented in the previous section are not
corrected for multiple testing. A naïve Bonferroni cor-
rection for 14 k variants would give a P value threshold
Fig. 4 Linkage disequilibrium across the two associated regions. Mountain plots generated by Haploview [38] for (a) rs9939609:T > A associated
region chr16:53,797,908-53,846,168 (48.3 kb) and (b) the novel associated region at chr16:54,812,014-54,865,446 (53.4 kb), across our complete
study group. Bright red represents D’ = 1 and LOD≥ 2 (complete dependence and strong evidence for linkage); shades of pink/red represent
D’ < 1 and LOD ≥ 2; blue represents D’ = 1 and LOD < 2; white represents D’ < 1 and LOD < 2(low dependency and poor evidence for linkage).
The full plot of the region sequenced is shown for reference (chr16:53500000-55500000)
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significance of 3.5 × 10−6 (=0.05/14000) when controlling
the family wise error rate (FWER) at the 5 % level. How-
ever, since the variants are not independent the above
correction is overly conservative. Indeed variants belong-
ing to the same linkage disequilibrium blocks have a
strong positive correlation (consider that we identify
multiple associating variants across both the known, and
our novel, regions). It is therefore more appropriate to
use the number of LD blocks (n = 226) identified by
Haploview to estimate the corrected P value threshold.
This then becomes 0.05/226 = 2.2 × 10−4. Only the known
LD region in the first intron of FTO and the second peak
of association identified above pass this threshold (Fig. 3),
guiding us to focus on these two regions only.
Since there is no exact definition of an LD block the
above multiple testing correction by the number of LD
blocks may be underestimated. This is why we decided
to control for FWER by permuting the set of obese and
control labels. This was achieved by a 100,000-permuta-
tion test in Haploview for the full set of sequenced vari-
ants across the 2 Mb in our cohort of 284 men. The
individual SNPs in the second peak of association have
corrected P values >0.05 and therefore do not pass mul-
tiple testing correction. This is a reflection of our limited
sample size and paradoxically the vast number of vari-
ants we identified through complete sequencing of the
region. Therefore it was essential that we replicate our
findings in other cohorts.
Replications
In order to validate our findings, we replicated our case-
control association tests in two larger cohorts (Table 3).
The first (Male GOYA) comprises 1,450 men from the
expanded cohort that our study group was initially selected
from [31]. The expanded group has imputed SNP data for
the three highest associating SNPs (rs7186407:A > T,
rs12598453:C >G and rs12596270:A >G) as well as for
rs9939609:T > A. The three highest associating SNPs,
which are in near perfect LD, were chosen to be represen-
tative of the second novel peak of association. We found
that in this larger group of young men, all three
representative SNPs also associate with the case group,
with a P value of 0.0054 (Table 3).
In addition, we replicated our association analysis of
the three representative SNPs in a large female Danish
cohort (Female GOYA) [31, 39]. We initially looked at
the entire cohort of 3,908 women (1,960 extremely over-
weight and 1,948 control women, total average age of
29.5). In this group, using imputed data for the three
representative SNPs, we cannot confidently replicate the
second association peak (P values >0.05, Table 3). How-
ever, in light of previous studies that suggest genetic
association to obesity at the FTO locus may be age-
dependent [26–28] and because of the lower, narrower
age range in our male cohort (mean = 19.9), we exam-
ined the role of age in this age-diverse female cohort
(range from 16 to 45). We find that the allele frequency
of the three SNPs is consistently higher in cases com-
pared with controls only for women aged under 25 years
(Additional file 10: Figure S8). In this smaller group of
562 individuals the three SNPs show significant associ-
ation with obesity (P value = 0.0014, Table 3). This is
consistent both with previous studies at the FTO locus
[26] and with the value found in the larger Male GOYA
cohort. If we consider all individuals aged less than
25 years in all cohort groups then the P value for the
association of the novel peak we found is 1 × 10−5
(Additional file 11: Figure S9) confirming that our
second novel peak of association can be replicated in-
dependently in larger cohorts of the same ethnic
background and similar age, regardless of gender.
IRX3 interactions extend beyond both BMI associated
regions
Recently, long-range interactions have been experi-
mentally defined across most of the 16q12.2 region
for the FTO and IRX3 genes using chromatin con-
formation analysis [21]. Comparing the locations of
these interactions with those of BMI-associated SNPs
might help determine both a mechanism and a role
for the SNP regions in the cis-regulation of the FTO
or IRX3 genes. Figure 5 shows that while neither the
FTO nor the IRX3 promoter-based 4C-seq data
Table 3 Replication data using SNP rs12598453:C > G as a representative of the three SNPs referred to in the text
Cohort Number of
individuals
Number of controls,
cases
AF in cases,
controls
P value, case-control
allelic chi-squared test
BMI averages by genotype:
CC, CG, GG
Sequenced men 284 161, 123 0.491, 0.646 0.00021 25.2, 26.03, 28.13
Male GOYA 1,450 785, 665 0.496, 0.547 0.0054 26.51, 26.89, 27.39
GOYA men, younger than 25 years 1,381 749, 632 0.493, 0.551 0.0027 26.45, 26.85, 27.47
Female GOYA 3,908 1948, 1960 0.507, 0.529 0.056 30.00, 30.21, 30.46
GOYA women, younger than 25 years 562 255, 307 0.465, 0.560 0.0014 29.79, 30.67, 32.5
All combined 5,401 2762, 2639 0.503, 0.534 0.0012 29.04, 29.24, 29.63
All combined, younger than 25 years 1,984 1032, 952 0.486, 0.556 0.000011 27.35, 27.85, 28.89
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correlate strongly with our associated regions, both
our regions are within the long-range interaction
architecture of IRX3, with particularly strong interac-
tions (both with FTO and IRX3) flanking the associ-
ated region upstream of IRX5. Hi-C data from human
embryonic stem cells also provides strong evidence that
our novel association region upstream of IRX5 plays a role
in many interactions across the TAD (Additional file 12:
Figure S10), including with the IRX3 and FTO gene
regions ([24] and http://yuelab.org/hi-c/). Further 4C-seq
analyses of our non-coding association regions will allow
us to understand which genes or other non-coding regions
of DNA these SNPs might be interacting with, and
whether the presence of this variation changes these inter-
action profiles.
Functional predictions for the novel BMI associated
region
Using publicly available data, we compared the novel
BMI associated region upstream of IRX5 with gene regu-
latory markers and functional annotations. This includes
(but is not limited to) the presence of CNEs, epigenetic
marks and interaction data (HiC). Selecting a relevant
cell line is a caveat of this approach, as the exact contri-
bution of this genomic region to BMI is not fully under-
stood, however a recent study suggests the contribution
of variation at the FTO locus affects adipocyte lipid
accumulation through increased IRX3 and IRX5 expres-
sion [40]. Within the novel region there are three CNEs
(Additional file 13: Figure S11). These highly constrained
regions are strong indicators of regulatory function. One
of these CNEs contains, and is surrounded by, a cluster of
conserved transcription factor binding sites (HMR Con-
served Transcription Factor Binding Sites). In addition,
ENCODE Genome Institute of Singapore ChiA-PET data
show interactions in our highlighted region for RNAPII
and CTCF long-range binding in two different cell lines
(K562 myelogenous leukaemia cells and MCF-7 breast
cancer cells). CTCF is thought to be a transcriptional
regulator [41] and therefore the presence of long-range
CTCF-mediated binding in this region suggests a potential
role in either repression or activation through DNA loop-
ing. The presence of RNAPII mediated looping can also
be indicative of enhancer activity in the region. These
Fig. 5 Comparison of association data with previously mapped FTO and IRX3 interactions. Association data for bi-allelic SNPs identified in this
study are mapped to the mm9 mouse genome build and represented in blue (methods). The IRX3 (green) and FTO (red) promoter interaction
data [21] are shown for the same region allowing a direct comparison of our SNP associations and previously published interaction data
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long-range interactions across the TAD are supported by
previous Hi-C data across the whole 2 Mb and suggest
that additional regulatory regions might contribute to the
gene expression of IRX3 and IRX5 (Additional file 14: Fig-
ure S12). Interestingly we are unable to find any positive
interaction data between our novel BMI association region
and the FTO gene (or any other genes within the TAD) in
the current literature.
Discussion and conclusions
Recently, the selective sequencing of regions of the hu-
man genome has been achieved using hybridisation cap-
ture approaches. This has largely been exploited to
sequence the coding, or exome, portions of the genome.
However, the same capture approach can also be
adapted to select any regions from the genome [42].
Here, unusually, we have employed it to capture a con-
tiguous megabase scale region of the human genome.
The 2 Mb interval was selected using 8,701 probes at
intervals of approximately 200 bp. Seventy-two gaps in
the sequence, largely repetitive and covering a total of
30.7 kb (1.5 % of total), were not traversable. Between 70
and 80 % of all reads map back to the region of interest
in our 284 study group samples providing good coverage
across 98.5 % of the interval, making the capture ap-
proach considerably more efficient than whole genome
sequencing. Furthermore, downstream analysis is con-
siderably simpler and less time-consuming. As a result,
we were able to generate very high coverage, (average
200-fold) which in practice means that almost every in-
dividual variant can be called with very high confidence.
We decided at the outset to sequence only those indi-
viduals that are homozygous at rs9939609. This allowed
very high resolution mapping of haplotypes, particularly
across the 44 kb LD region associated with this SNP.
One of the aims was to determine whether, within the
Danish study group we sequenced, there were any low
frequency variants that contributed a significant effect
within this region and would therefore allow further dis-
section of the association with BMI. It was also easier to
determine whether the association of other variants
across the 2 Mb interval with BMI was linked to, or in-
dependent of, the 44 kb LD region. Consistent with
other studies [43], particularly in European populations,
the 44 kb region is in almost complete LD. Incredibly, of
282 SNPs we mapped across the 44 kb, only one
(rs16952522:C > G at 53,807,498) is found in common
between the rs9939609 ‘A’ and ‘T’ alleles (MAF 0.045 in
cases, 0.037 in controls). This implies that at least in the
Danish population, recombination events in this region
are historically exceptionally rare. The small size of our
study group means that we do not have the statistical
power to evaluate whether any of the rs9939609 ‘A’ risk
allele sub-haplotypes or rare variants are more associ-
ated with obesity than others.
Analysis of the constrained sequences within the re-
gion confirms that there are no coding variants nor any
frequently occurring variants in highly conserved non-
coding elements (CNEs) that are associated with ele-
vated BMI. Functional constraint does have an effect on
both the frequency of variant locations (4.1, 5.6 and 7.0
per kb, respectively, for coding, CNE and non-coding se-
quence) and the minor allele frequency of variants (85 %
of coding, 80 % of CNE and 70 % of non-coding variants
have MAF < 0.1).
Within our Danish male study group, we clearly iden-
tify a second, novel region associated with BMI in non-
coding sequence upstream of the IRX5 gene. Individuals
in our study group who are homozygous for this second
region have a mean BMI elevated to a similar extent to
the effect of the known FTO intron region variants. This
association is independent of the FTO LD region as it is
not present if we compare A/A vs. T/T individuals. Our
analysis was performed using data obtained at Danish
draft board assessment which results in a very homoge-
neous study group, not only in terms of gender and eth-
nicity but also because all participants were of similar
age (average age 19.9 years) when their BMI was mea-
sured. Interestingly, this association is strongest in youn-
ger sub-groups of our replication cohorts as well,
suggesting an age-dependence aspect.
To address this idea, we first used imputed values for
the three most highly associating variants upstream of
IRX5 in the expanded male cohort, comprising 1,450 indi-
viduals, to confirm the association. Next, we used imputed
values for the same three SNPs in a completely independ-
ent female Danish study group, comprising nearly 4,000
individuals. When we use the entire cohort with a higher
average age, the association is not clear but in women
aged under 26 years we replicate the association. Thus, if
we match the male and female cohorts by age (as far as
possible), there remains a significant association between
BMI and the region upstream of IRX5.
We then searched for the 22 highest associating SNPs
across the second peak of association in the GIANT con-
sortium BMI based anthropometric data for European
populations [44]. Of these 22 SNPs, 13 are included in the
GIANT dataset, with over 200,000 individuals having data
for these variants, yet none of these SNPs are found to
have a significant association with obesity. It is impossible
to discern the reason for the lack of an association in the
GIANT consortium data without secondary analyses.
Nevertheless, in our analyses the association is lost as age
increases, perhaps because environmental factors such as
diet and levels of physical activity are likely to have an
increasing impact on BMI with age, confounding the
detection of some genetic associations. Conversely, if the
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genetic consequences of this association are established
early in life, such as during development, then it is likely
that a stronger association will be seen at a younger age.
Given that this locus is intimately associated with complex
developmental transcription factors, this would seem
highly likely and reflect the life course data at the neigh-
bouring FTO gene [26].
The IRX genes, including IRX3 and IRX5, play com-
plex and overlapping developmental roles in multiple
tissues and organs [45, 46]. There is also evidence that
both IRX clusters form complex interactions that define
specific three-dimensional structures that regulate gene
expression at different loci [23, 47]. In particular, it has
been shown that the IRX3 promoter region interacts
with a number of distal sites across the 2 Mb region [21]
sequenced here and defined by the embryonic stem cell
line TAD described previously [24].
In order to examine this in detail, we first looked at
the overlap between the interaction data for FTO and
IRX3 genes and our association data across the region.
As the interaction data are from mouse, we lifted our
human data for the region over to the syntenic region
on mouse chromosome 8 (methods). There is no strong
correlation between IRX3 (or FTO) interactions and
either of the BMI-associated regions although there is
some IRX3 and FTO signal across the 44 kb region.
However, the fact that long-range IRX3 interactions
occur up to and beyond both associated regions suggests
architecture is an important aspect of gene regulation
across the whole region. This is supported by Hi-C
interaction data across the TAD from human embry-
onic stem cells [24], which clearly show strong inter-
actions between the FTO and IRX5 gene regions. It
will therefore be important to establish the specific
interaction domains of IRX5 and IRX6 in order to
get a fuller picture of the complex structure of this
region and to be able to place the associated regions
into a fuller context.
Despite many GWAS studies [37] and now the full
sequencing of this region from a well-defined study
group, there remains considerable difficulty in predict-
ing, describing or functionally assaying the impact of
non-coding variants on disease or phenotype. As a re-
sult, a number of the genes across this region have been
implicated in obesity yet without any clear mechanism
of regulatory control [48, 49]. This region is particularly
complex because of the presence of the IRXB cluster, a
set of homologous genes that regulate many aspects of
early development and are thus under tight regulatory
control themselves. This control is likely to be mediated
via cis-regulatory sequences that in some cases may be
hundreds of kb away and even within the non-coding
regions of other genes, as has been demonstrated for
other genes such as Shh [50, 51].
The implication of more than one gene in the aeti-
ology of obesity at this locus may therefore not be so
surprising, neither is the identification of a second clus-
ter of associating SNPs. The structural architecture(s) of
this particular topologically associated domain (TAD)
may have profound effects on the regulation of all the
genes in the region at some stage, but at this juncture
we do not know enough about how sequence vari-
ation may alter chromatin architecture nor what the
consequences might be in terms of gene expression.
Nevertheless, as we gain more insight into the struc-
ture and function of the non-coding DNA in this
TAD, the complete sequence of the 2 Mb interval
from this study group will provide a valuable re-
source. Furthermore, targeted region sequencing may
be of great utility in examining other such complex
regions in fine detail in the future.
Methods
Sequencing
Samples were curated and individuals were assessed as
described previously [28]. Libraries were prepared for se-
quencing using Illumina Nextera Rapid Capture Custom
Enrichment Kit (Cat ID FC-140-1009). The custom kit
included 8,701 probes across the 2 Mb region for 288
samples (Project ID 44309). All samples were run on an
Illumina HiSeq 2500 at 100 cycle pair end reads. Ninety-
six multiplexed samples were run per flow cell with each
multiplex being run twice on Rapid Run mode. Samples
were de-multiplexed and converted to FASTQ files using
Illumina software CASAVA.
Ethical statement
The study was approved by the regional scientific ethics
committee and by the Danish Data Protection Board
and fulfilled the Helsinki Declaration.
Availability of supporting data
Sequence data (reads) will be available through ENA at
http://www.ebi.ac.uk/ena. Accession number PRJEB11794.
All other data are contained within the paper or supple-
mentary information files. All other data is fully available
on request, without restriction.
Mapping and variant calling
We mapped sequencing data (FASTQ) files to the hg19
assembly of the human genome, the version in
human_g1k_v37.fasta file available from the 1000 Genomes
Project (ftp://ftp.1000genomes.ebi.ac.uk/vol1/ftp/technical/
reference/). We use BWA (Burrows-Wheeler Aligner) soft-
ware to map the reads [52], version bwa-0.7.8, bwa-mem
algorithm with default parameters. The mapped read (sam)
files were then converted to bam format using samtools
version 0.1.19 [53]. The reads in each bam file were then
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sorted by chromosome and coordinate and indexed using
samtools. Duplicate reads were marked by Picard (http://
broadinstitute.github.io/picard), version 1.91, MarkDupli-
cates tool. Then the two bam files from different sequen-
cing runs for each individual were merged using Picard
tool MergeSamFiles. At this point we have one bam file
per individual. These bam files were then processed by our
in-house tool ‘TidyVar’ (B. Noyvert and G. Elgar, manu-
script in preparation), which is an implementation of a
novel variant calling algorithm. The algorithm uses string
matching approach to detect SNPs and short insertions
and deletions, the individual genotypes are assigned using
pattern recognition. A single vcf file listing all the variants
found in all the individuals is produced. We also scanned
our sequencing data for copy-number variations (CNV) by
looking for abnormal coverage fluctuations. The detected
CNVs were then confirmed by the presence of reads bridg-
ing over the suspected region.
Haplotype analysis
Haplotyping was performed with Haploview [38] using
the methods described previously for defining linkage
disequilibrium blocks [43]. For this programme, only bi-
allelic SNPs were used across the region chr16:53,500,000-
55,500,000. Comparisons over each variant over 500 kb
were performed and settings altered from default to ignore
Hardy-Weinberg P values, and to include only individuals
with a minimum of 75 % of all SNPs successfully called.
Associations of individual variants and haplotypes
were produced through Haploview using the case-
control allelic chi-squared test with one degree of
freedom for the 2 × 2 contingency table of allele
counts for reference and non-reference alleles and for
case and control separately [54]. The output P values
of this were used throughout this study.
Interaction data liftOver
The UCSC genome browser utility liftOver (http://geno
me.ucsc.edu/cgi-bin/hgLiftOver) was used as the Batch
Coordinate Conversion method to transfer SNP hg19
coordinates to mouse genome build mm9 coordinates
using default settings. Conversion of 5,842 SNPs was
successful with 5,988 SNP locations failing.
Genotyping and imputation of replication cohorts
Genome-wide genotyping on the Illumina 610 k quad
chip was carried out at the Centre National de Genoty-
page (CNG), Evry, France. We excluded SNPs with
minor allele frequency <1 %, >5 % missing genotypes or
which failed an exact test of Hardy-Weinberg equilib-
rium (HWE) in the controls (P <10−7). We also excluded
any individual who did not cluster with the CEU individ-
uals (Utah residents with ancestry from northern and
western Europe) in a multidimensional scaling analysis
seeded with individuals from the International HapMap
release 22, who had >5 % missing data, outlying hetero-
zygosity of >35 % or <30.2 %, genetic duplicates, one of
each pair of genetically related individuals, individuals
with sex discrepancies and one individual whose geno-
typing was discordant with a previous project. We car-
ried out imputation to HapMap release 22 (CEU
individuals) using Mach 1.0, Markov Chain Haplotyping.
This method was used for both the Male and Female
GOYA cohorts [31, 39]. Imputed genotypes for the
sequenced 284 men (where available) were compared to
the sequenced genotypes called by TidyVar and found to
be correct 100 % for rs9939609:T > A and 98.3 % correct
for the SNPs rs7186407:A > T, rs12598453:C > G and
rs12596270:A > G.
Topological association domain comparison
The –log10(P value) for association of each SNP with
the case or control cohort was used in preparation of a
variable step .wig file with a scale of 0 to 6 and each line
to span 1 base. The coordinates for each SNP were con-
verted using UCSC LiftOver from hg19 to hg18 to fit
with the original scaffold used for the Hi-C data. The
data we have used for the Hi-C tracks are limited to
human embryonic stem cells (hESC). Default max (50)
and min (10) values were used for the heat map visual-
isation ([24] and http://yuelab.org/hi-c/).
Data sources
CNE locations were taken from CONDOR [25]. Exon
coordinates were taken from Ensembl Biomart release ver-
sion 75 [55]. All sequence coordinates in this study are
from GRCh37/hg19. 1KG (100 genomes) variant data are
taken from the publicly available ‘ALL.chr16.phase1_relea-
se_v3.20101123.snps_indels_svs.genotypes.vcf.gz’ VCF file
found at ftp://ftp.1000genomes.ebi.ac.uk/vol1/ftp/release/
20110521/.
All dbSNP variants are taken from the NCBI publicly
available ‘human_9606_b142_GRCh37p13/VCF/All.vcf.gz’
VCF file found at ftp://ftp.ncbi.nlm.nih.gov/snp/organisms/.
Epigenomic data were sourced and visualised through
the WashU Epigenome Browser (http://epigenomegate
way.wustl.edu/) using ENCODE GIS Chia-Pet publicly
available data [56].
Additional files
Additional file 1: Table S1. Sample IDs, BMIs, ages and case/control
classifications for the samples that were included in this study that
passed quality control (n = 284). (DOCX 41 kb)
Additional file 2: Figure S1. Summary chart of the number of
samples where 90 % of bases have coverage of the different bin
values. (TIF 1718 kb)
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Additional file 3: Figure S2. Distribution of SNPs at the 16q12.2 locus
that fall within CNEs (CONDOR) associated with the IRXB cluster. Control
frequencies are in blue and case frequencies are in red. (TIF 7312 kb)
Additional file 4: Figure S3. Distribution of SNPs at the 16q12.2 locus
that fall within coding regions. Control frequencies are in blue and case
frequencies are in red. (TIF 4857 kb)
Additional file 5: Figure S4. Cumulative frequency distribution of
variants in CNEs (blue), coding regions (green) and all variants across the
region (red). (TIF 1973 kb)
Additional file 6: Figure S5. Association plot of the –log10 (P value) of
all SNPs across the locus with rs9939609:AA. (TIF 1708 kb)
Additional file 7: Table S2. All associating haplotypes (P value <0.05)
from the Haploview LD block definitions with MAF >0.05. (DOCX 24 kb)
Additional file 8: Figure S6. As Figure S6 but re-scaled and with the
large peak from AH44 removed. Y-axis scale bar is the same as that
of Fig. 3 for comparison. Together, Fig. 3 and Figure S6 show that the second
peak of association is independent from the AH44 associated haplotype.
(TIF 1741 kb)
Additional file 9: Figure S7. Plot of the –log10 (P value) for association
of all SNPs across the locus using a randomly shuffled case and control
definition for the whole study group. (TIF 7304 kb)
Additional file 10: Figure S8. Allele frequencies by age in Female
GOYA cohort. The case allele frequency (AF) is shown in red, the control
AF is shown in blue. The allele frequencies are calculated in groups of
400 individuals of consecutive age. While the case AF is consistently
larger than control AF for rs9939609:T > A across essentially the entire
age range, the consistent AF difference for rs12598453:C > G is only
observed in younger (age up to approximately 25 years) women.
(TIFF 6788 kb)
Additional file 11: Figure S9. Age dependence of SNP rs12598453:C >
G association to obesity. Each point on the plot represents the
association P value (on y-axes) for a subgroup of combined GOYA male
and female cohorts younger than a certain age (on x-axes). (TIF 70 kb)
Additional file 12: Figure S10. Comparison of our SNP association data
with previously published Hi-C data. Our two significant SNP association
peaks lie within interacting domains within the previously defined TAD [24].
(TIF 1540 kb)
Additional file 13: Figure S11. UCSC browser figure of the second
association peak region (54820000-54860000). (TIF 36 kb)
Additional file 14: Figure S12. WashU epigenome browser figure. The
entire region sequenced is shown. Highlighted in yellow is the second
novel peak of association we have identified. (TIF 226 kb)
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